Foresee Pharmaceuticals Co (ROCO:6576) Total Liabilities: NT$380.8 Mil (As of Dec. 2025)


ROCO:6576 Foresee Pharmaceuticals Co Ltd ROCO:6576
58 GF Score
Price NT$83.10
GF Value NT$96.70
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Foresee Pharmaceuticals Co Total Liabilities?

Foresee Pharmaceuticals Co ROCO:6576 58 Total Liabilities is NT$380.8 Mil as of Dec. 2025. GuruFocus rates ROCO:6576 with a GF Score™ of 58/100 and a GF Value™ of NT$96.70 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Foresee Pharmaceuticals Co's Total Liabilities for the quarter that ended in Dec. 2025 was NT$380.8 Mil.

Foresee Pharmaceuticals Co's quarterly Total Liabilities declined from Jun. 2025 (NT$593.99 Mil) to Sep. 2025 (NT$510.20 Mil) and declined from Sep. 2025 (NT$510.20 Mil) to Dec. 2025 (NT$380.78 Mil).

Foresee Pharmaceuticals Co's annual Total Liabilities declined from Dec. 2023 (NT$616.93 Mil) to Dec. 2024 (NT$560.15 Mil) and declined from Dec. 2024 (NT$560.15 Mil) to Dec. 2025 (NT$380.78 Mil).

Foresee Pharmaceuticals Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Foresee Pharmaceuticals Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foresee Pharmaceuticals Co Total Liabilities Chart

Foresee Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 321.26 393.43 616.93 560.15 380.78

Foresee Pharmaceuticals Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 560.15 377.56 593.99 510.20 380.78
ROCO:6576
58GF Score
Foresee Pharmaceuticals Co Ltd ROCO:6576
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Foresee Pharmaceuticals Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Foresee Pharmaceuticals Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=286.304+(20.505+73.968
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=380.8

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1310.391-929.614
=380.8

Foresee Pharmaceuticals Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=286.304+(20.505+73.968
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=380.8

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=1310.391-929.614
=380.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$380.8 Mil mean?
Foresee Pharmaceuticals Co (ROCO:6576) has a Total Liabilities of NT$380.8 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Foresee Pharmaceuticals Co and its competitors.
Is Foresee Pharmaceuticals Co's Total Liabilities too high?
Foresee Pharmaceuticals Co's current Total Liabilities is NT$380.8 Mil. Overall, Foresee Pharmaceuticals Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Foresee Pharmaceuticals Co's Total Liabilities compare to ZTS and UTHR?
Foresee Pharmaceuticals Co's Total Liabilities of NT$380.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Foresee Pharmaceuticals Co and its competitors. Foresee Pharmaceuticals Co's current Total Liabilities is NT$380.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Foresee Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Foresee Pharmaceuticals Co (ROCO:6576) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$96.70, compared to a current price of NT$83.10 — trading 14.1% below its estimated fair value. The current Total Liabilities is NT$380.8 Mil. Foresee Pharmaceuticals Co's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Foresee Pharmaceuticals Co (ROCO:6576), the current Total Liabilities is NT$380.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Foresee Pharmaceuticals Co (ROCO:6576) Overvalued in 2026?

Based on GuruFocus' analysis, Foresee Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$83.10 is trading 14.1% below its estimated GF Value™ of NT$96.70. GuruFocus considers Foresee Pharmaceuticals Co to be Modestly Undervalued.

Key valuation signals for ROCO:6576:

  • Total Liabilities: NT$380.8 Mil
  • GF Value™: NT$96.70 vs. price of NT$83.10 (14.1% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Foresee Pharmaceuticals Co Business Description

Address No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115
Foresee Pharmaceuticals Co Ltd main activity is applying stabilized injectable formulation (SIF) platform technology to produce products for anticancer and treatment of chronic diseases. Its pipeline includes CAMCEVI (Leuprolide, FP-001), FP-014 (Triptorelin), Aderamastat (FP-025, MMP-12 Inhibitor), Linvemastat (FP-020, MMP-12 Inhibitor), and others. The Group operates business only in a single industry of new drug development, and all of its revenue is generated from Taiwan.
58GF Score

Get the complete analysis for ROCO:6576

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$83.10
Price
NT$96.70
GF Value